Related Experiment Video
Updated: Jun 26, 2026

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice
Published on: May 23, 2021
Microvolt T-wave alternans as a predictor of mortality and severe arrhythmias in patients with left-ventricular
Charlotte J van der Avoort1, Kristian B Filion, Nandini Dendukuri
1Department of Medicine, McGill University Health Center, Montreal, Quebec, Canada. charlotte.vanderavoort@gmail.com
Insights
Microvolt T-wave alternans (MTWA) can help identify patients with severe left ventricular dysfunction at higher risk for mortality or arrhythmias. Further research is needed to fully define its clinical utility in guiding implantable cardioverter defibrillator decisions.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Diagnostics
Background:
- Implantable cardioverter defibrillators (ICDs) are effective for primary prevention of arrhythmic events.
- High costs necessitate identifying patients who benefit most from ICDs.
- Microvolt T-wave alternans (MTWA) is a potential tool for patient stratification.
Purpose of the Study:
- To evaluate MTWA as a predictor of mortality and severe arrhythmic events in patients with severe left-ventricular dysfunction.
- To synthesize evidence from randomized controlled trials and prospective cohort studies.
Main Methods:
- Systematic literature search of multiple databases (MEDLINE, EMBASE, etc.) from January 1990 to May 2007.
- Inclusion of primary prevention randomized controlled trials and prospective cohort studies with ≥12 months follow-up.
- Bayesian hierarchical models used for data synthesis.
Main Results:
- Analysis of 8 cohort studies with 1,946 patients; no trials identified.
- Positive MTWA test results were associated with a higher risk of mortality or severe arrhythmic events (RR = 2.7, 95% CrI = 1.4, 6.1).
- Similar findings observed when comparing non-negative MTWA results to negative results.
Conclusions:
- A positive MTWA test predicts adverse outcomes in severe left ventricular dysfunction.
- The clinical utility of MTWA is incompletely defined due to a wide credible interval.
- High-quality studies are needed to refine MTWA's role in ICD implantation decisions.
Background:
Studies have demonstrated that the use of implantable cardioverter defibrillators (ICDs) is effective for the primary prevention of arrhythmic events but due to imposing costs, there remains a need to identify which patients will derive the greatest benefit. Microvolt T-wave alternans (MTWA) has been proposed to assist in this stratification.
Methods:
We systematically searched the literature using MEDLINE, EMBASE, Current Contents, the Cochrane Library, INAHTA, and the Web of Science to identify all primary prevention randomized controlled trials and prospective cohort studies with at least 12 months of follow-up examining MTWA as a predictor of mortality and severe arrhythmic events in patients with severe left-ventricular dysfunction. The search was limited to full-text English publications between January 1990 and May 2007. The primary outcome was a composite of mortality and severe arrhythmias. Data were synthesized using Bayesian hierarchical models.
Results:
We identified no trials and 8 published cohort studies involving a total of 1,946 patients, including 332 positive, 656 negative, 84 indeterminate, and 874 non-negative (which includes both positive and indeterminate tests) MTWA test results. The risk of mortality or severe arrhythmic events was higher in patients with a positive MTWA compared to a negative test (RR = 2.7, 95% credible interval (CrI) = 1.4, 6.1). Similar results were obtained when comparing non-negative MTWA to a negative test.
Conclusion:
A positive MTWA test predicts mortality or severe arrhythmic events in a population of individuals with severe left ventricular dysfunction. However, the wide credible interval suggests the clinical utility of this test remains incompletely defined, ranging from very modest to substantial. Additional high quality studies are required to better refine the role of MTWA in the decision making process for ICD implantation.
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Dysrhythmias V: Evaluating Dysrhythmias
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Dysrhythmias VI: Management of Dysrhythmias
Mechanism of Cardiac Arrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
